Explore Q1 2025's biotech stock moves, from CervoMed's 300% surge to Septerna's struggles. Click for my review of the quarter ...

Exelixis, Inc. EXEL announced that the FDA has approved the label expansion of its lead drug Cabometyx (cabozantinib). The ...

A class action lawsuit was filed against ModivCare, Inc. (MODV) by Levi & Korsinsky on January 29, 2025. The plaintiffs ...

TCPA class actions can be incredibly scary and pose a massive risk to callers of all sorts. While the statute has generally ...

NEW YORK, NY / ACCESS Newswire / April 1, 2025 / If you suffered a loss on your Neumora Therapeutics, Inc. (NASDAQ:NMRA) investment and want to ...

When people tell you the statute of limitations for a TCPA violation is four years– we really mean it. Back on March 25, 2021 ...

Landmark Theatres’ victory in a proposed Video Privacy Protection Act class action was affirmed by a federal appeals court ruling Thursday that the law covers movie rentals, not “a classic in-theater ...

Novo Nordisk (NVO) closed the most recent trading day at $69.30, moving -1.23% from the previous trading session. The stock's performance was ahead of the S&P 500's daily loss of 1.97%.

The Seventh Circuit on Friday revived a proposed class action video privacy case against MeTV accusing the company of ...

In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against the other best ADR stocks. American Depositary Receipts (ADR) are US-listed securities that ...